Rx-To-OTC Switch Guidance May Be Issued By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA's Division of OTC Drug Products is considering issuing a guidance on the type of data that should be included in an NDA supporting an Rx-to-OTC switch
You may also be interested in...
OTC Sale Of Rx Allergy Drugs Would Be Safer, Cut Costs - Health Plan
Nonsedating antihistamines classified as prescription drugs would be more appropriately sold as OTCs, Blue Cross of California Pharmacy VP Rob Seidman maintains in Jan. 12 letters sent to marketers of the drugs.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands